scholarly article | Q13442814 |
P50 | author | Jacqueline M. Katz | Q87082629 |
Ruben O Donis | Q87441189 | ||
Suryaprakash Sambhara | Q104742683 | ||
Suresh K Mittal | Q104783680 | ||
Sai V Vemula | Q114722175 | ||
P2093 | author name string | Omar Amen | |
P2860 | cites work | Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine | Q21134724 |
THE ORIGINS OF NEW PANDEMIC VIRUSES: The Acquisition of New Host Ranges by Canine Parvovirus and Influenza A Viruses | Q22255612 | ||
Roles of antimicrobial peptides such as defensins in innate and adaptive immunity | Q24675023 | ||
Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens | Q28206241 | ||
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets | Q29619972 | ||
Production of adenovirus vectors and their use as a delivery system for influenza vaccines | Q30226988 | ||
Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus | Q30229074 | ||
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function | Q30233581 | ||
New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice. | Q30365380 | ||
A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. | Q30369294 | ||
The public health impact of avian influenza viruses. | Q30375470 | ||
Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses. | Q30382097 | ||
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host | Q30418377 | ||
In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines | Q30832171 | ||
Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunity | Q33713956 | ||
Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA | Q33785071 | ||
β-defensin 2 as an adjuvant promotes anti-melanoma immune responses and inhibits the growth of implanted murine melanoma in vivo | Q34163480 | ||
Mammalian defensins in immunity: more than just microbicidal | Q34647756 | ||
Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes | Q35353052 | ||
Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection. | Q35689651 | ||
Defensin participation in innate and adaptive immunity | Q36990379 | ||
Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice | Q37331004 | ||
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes | Q37680808 | ||
Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted | Q39683618 | ||
Recombinant mouse beta-defensin 2 inhibits infection by influenza A virus by blocking its entry | Q39733468 | ||
Expression of mouse beta-defensin-3 in MDCK cells and its anti-influenza-virus activity | Q39870557 | ||
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1. | Q40516862 | ||
Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis | Q40568230 | ||
Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. | Q40692879 | ||
Induction of TLR4-dependent CD8+ T cell immunity by murine β-defensin2 fusion protein vaccines | Q45188786 | ||
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. | Q45729695 | ||
DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses | Q45731543 | ||
Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. | Q45771024 | ||
A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide. | Q47991688 | ||
Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity | Q74649982 | ||
P433 | issue | 2 | |
P921 | main subject | influenza vaccine | Q383260 |
Adenoviridae | Q193447 | ||
P304 | page(s) | 398-403 | |
P577 | publication date | 2013-09-17 | |
P1433 | published in | Virus Research | Q15749215 |
P1476 | title | Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time | |
P478 | volume | 178 |
Q56901675 | A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose |
Q40093625 | Foreign gene expression and induction of antibody response by recombinant fowl adenovirus-9-based vectors with exogenous promoters |
Q90461228 | Immunologic Dose-Response to Adenovirus-Vectored Vaccines in Animals and Humans: A Systematic Review of Dose-Response Studies of Replication Incompetent Adenoviral Vaccine Vectors when Given via an Intramuscular or Subcutaneous Route |
Q30369109 | Intranasal immunization of recombinant Lactococcus lactis induces protection against H5N1 virus in ferrets. |
Q89514236 | Porcine β-defensin 2 inhibits proliferation of pseudorabies virus in vitro and in transgenic mice |
Q47557198 | Towards the Application of Human Defensins as Antivirals |
Q50111769 | Β-defensins - Underestimated peptides in influenza combat |
Search more.